Financials Spineway

Equities

ALSPW

FR001400N2P2

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris 11:35:06 2024-04-26 am EDT 5-day change 1st Jan Change
0.855 EUR +6.86% Intraday chart for Spineway -18.40% -87.43%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 - - - - - -
Enterprise Value (EV) 1 - - - - - -
P/E ratio - - - - - -
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA - - - - - -
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - - - - 0.01 x
Nbr of stocks (in thousands) - - - - - -
Reference price 2 17,360,000 600,000 96,000 64,000 2,100 6.800
Announcement Date 5/2/19 4/17/20 1/27/21 2/2/22 2/20/23 4/11/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 6.911 5.586 4.512 5.035 8.532 11.36
EBITDA 1 -3.168 -1.547 -1.335 -1.291 -2.988 -3.382
EBIT 1 -3.878 -2.325 -1.952 -1.41 -3.326 -4.516
Operating Margin -56.11% -41.62% -43.26% -28% -38.98% -39.76%
Earnings before Tax (EBT) 1 -4.124 -2.876 -14.1 -1.583 -3.137 -6.51
Net income 1 -4.124 -2.876 -14.1 -1.583 -3.137 -6.51
Net margin -59.67% -51.49% -312.61% -31.44% -36.77% -57.32%
EPS - - - - - -
Free Cash Flow 1 -2.642 -5.101 -0.4232 -2.476 -14.04 -3.64
FCF margin -38.22% -91.31% -9.38% -49.17% -164.59% -32.05%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/2/19 4/17/20 1/27/21 2/2/22 2/20/23 4/11/24
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 3.77 1.84 - - - 0.81
Net Cash position 1 - - 2.17 11.6 4.09 -
Leverage (Debt/EBITDA) -1.189 x -1.187 x - - - -0.2407 x
Free Cash Flow 1 -2.64 -5.1 -0.42 -2.48 -14 -3.64
ROE (net income / shareholders' equity) -303% -77.3% -171% -10.2% -14.6% -31.7%
ROA (Net income/ Total Assets) -28% -14.4% -8.87% -4.37% -7.81% -10.5%
Assets 1 14.75 19.99 159.1 36.21 40.19 62.28
Book Value Per Share - - - - - 1,268
Cash Flow per Share - - - - - 120.0
Capex 1 1.02 5.21 0.98 1.09 12.3 0.55
Capex / Sales 14.76% 93.32% 21.74% 21.55% 143.85% 4.82%
Announcement Date 5/2/19 4/17/20 1/27/21 2/2/22 2/20/23 4/11/24
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.855 EUR
Average target price
1.8 EUR
Spread / Average Target
+110.53%
Consensus

Annual profits - Rate of surprise